Gamco Investors INC. ET AL Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)

Gamco Investors INC. ET AL raised its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 18.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 108,957 shares of the company's stock after purchasing an additional 17,334 shares during the period. Gamco Investors INC. ET AL owned about 0.06% of Option Care Health worth $2,528,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in the company. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health during the fourth quarter valued at $26,000. UMB Bank n.a. lifted its stake in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC lifted its stake in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC lifted its stake in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after acquiring an additional 1,099 shares during the period. Finally, Sterling Capital Management LLC lifted its stake in Option Care Health by 638.5% in the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock worth $69,000 after acquiring an additional 2,554 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Monday. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Option Care Health has an average rating of "Moderate Buy" and an average price target of $33.75.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.64% of the company's stock.

Option Care Health Stock Up 1.9 %

Shares of OPCH traded up $0.60 during mid-day trading on Wednesday, hitting $32.14. 176,770 shares of the company traded hands, compared to its average volume of 1,785,669. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $5.28 billion, a PE ratio of 27.01, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The business has a 50 day moving average of $33.31 and a 200 day moving average of $28.68.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.